2014 Diagnostic Disease Radiopharmaceuticals 
AuntMinnie
APRIL 4, 2024
Life Molecular Imaging (LMI) and Sofie Biosciences have begun offering the Neuraceq ( florbetaben F-18) PET radiotracer produced at Sofie's radiopharmaceutical manufacturing site in Cleveland, Ohio. With this expansion, LMI continues driving commercial sales of Neuraceq around the U.S.
Imaging Technology
JUNE 10, 2024
For over three decades, Anderson’s pioneering research has laid the foundation for the growth of radiometal-based agents for diagnostic imaging and targeted radionuclide therapy of cancer, a field now known as "theranostics." Louis , Missouri, where she worked more than 20 years developing PET and radiopharmaceutical therapy agents.
Expert insights. Personalized for you.
95 
Let's personalize your content